Addus HomeCare (NASDAQ:ADUS) Given New $101.00 Price Target at Barclays

Key Points

• Barclays raised its Addus HomeCare price target to $101 from $96 but maintained an “underweight” rating, implying about 20% downside from the stock’s previous close.
• Analyst sentiment overall is more positive: the stock has a “Moderate Buy” consensus rating and an average price target of $129.89.
• Addus reported quarterly EPS of $1.83, beating the $1.79 consensus estimate; revenue was $387.74 million, slightly below estimates, but rose 7% year over year.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) had its price target upped by Barclays from $96.00 to $101.00 in a report issued on Wednesday, Benzinga reports. The firm presently has an "underweight" rating on the stock. Barclays's target price points to a potential downside of 19.95% from the stock's previous close.

Several other equities analysts also recently commented on the stock. Weiss Ratings raised shares of Addus HomeCare from a "hold (c)" rating to a "hold (c+)" rating in a research note on Thursday, September 24th. Citigroup cut shares of Addus HomeCare from a "market outperform" rating to a "neutral" rating in a research note on Monday, September 14th. Raymond James Financial set a $137.00 price target on shares of Addus HomeCare in a report on Monday, September 28th. Royal Bank Of Canada increased their price target on Addus HomeCare from $130.00 to $134.00 and gave the company an "outperform" rating in a research note on Wednesday, August 5th. Finally, Bank of America downgraded Addus HomeCare from a "buy" rating to a "neutral" rating and cut their price objective for the company from $140.00 to $125.00 in a report on Monday, September 14th. One investment analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating, four have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $129.89.

Addus HomeCare Price Performance

Shares of NASDAQ ADUS traded down $0.39 during trading hours on Wednesday, hitting $126.17. 141,082 shares of the stock were exchanged, compared to its average volume of 235,764. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.69 and a current ratio of 1.69. The company has a market cap of $2.36 billion, a PE ratio of 22.17, a price-to-earnings-growth ratio of 1.79 and a beta of 0.75. The company's fifty day simple moving average is $117.22 and its two-hundred day simple moving average is $106.62. Addus HomeCare has a 1-year low of $87.95 and a 1-year high of $127.84.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last announced its quarterly earnings data on Tuesday, November 3rd. The company reported $1.83 EPS for the quarter, beating the consensus estimate of $1.79 by $0.04. The business had revenue of $387.74 million during the quarter, compared to the consensus estimate of $388.72 million. Addus HomeCare had a net margin of 7.13% and a return on equity of 9.96%. The company's revenue was up 7.0% on a year-over-year basis. During the same period in the previous year, the business earned $1.56 earnings per share. On average, sell-side analysts predict that Addus HomeCare will post 6.33 EPS for the current year.

Hedge Funds Weigh In On Addus HomeCare

A number of hedge funds have recently modified their holdings of ADUS. BlackRock Inc. acquired a new position in Addus HomeCare during the 2nd quarter worth about $344,153,000. Dimensional Fund Advisors LP grew its position in shares of Addus HomeCare by 11.8% in the 1st quarter. Dimensional Fund Advisors LP now owns 744,127 shares of the company's stock valued at $69,689,000 after buying an additional 78,415 shares during the last quarter. Bank of America Corp DE acquired a new stake in shares of Addus HomeCare in the second quarter valued at about $35,527,000. TimesSquare Capital Management LLC acquired a new stake in shares of Addus HomeCare in the second quarter valued at about $31,502,000. Finally, Punch & Associates Investment Management Inc. bought a new position in shares of Addus HomeCare during the second quarter worth about $20,911,000. Institutional investors and hedge funds own 95.35% of the company's stock.

About Addus HomeCare

Addus HomeCare Inc NASDAQ: ADUS provides in-home personal care, hospice and home health services to older adults, people with disabilities and other individuals who need assistance with daily living or medical care. Its services are designed to help clients remain safely and independently in their homes while supporting families and caregivers.

The company's personal care services include assistance with bathing, dressing, grooming, meal preparation, housekeeping and other activities of daily living.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.